Susan Hasty, Publisher
Table of Contents . . . July 25th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Gene Therapy Weekly | Other Publications
Antisense Gene Therapy - Blocking integrin subunits could refine approach to cancer treatment
Liver Therapy - Vector dampens liver cell resistance to gene therapy
Lung Cancer - Certain retinoids able to override nicotine effects better than others
Ovarian Cancer - Multiple dose gene therapy yields best results in recurrent ovarian cancer
Pancreatic Cancer - Strategy utilizes fibroblast growth factor receptors for targeting cancer
Appointments - Psychiatric Genomics, Inc., names Bradley Lorimier to board of directors
Cancer Therapy - St. Jude study shows gene therapy offers hope to chemotherapy patients
Colorectal Cancer - Positive preliminary results of phase I trial for Nv1020 presented at ASCO meeting
Cystic Fibrosis - Copernicus nonviral gene transfer system corrects chloride channel defect
Electroporation - Genetronics announces advances in in vivo gene delivery
Genetic Testing - New studies support BRCAAnalysis for breast and ovarian cancer
Small Cell Lung Cancer - Antisense oligodeoxynucleotides cut off peptide receptors in human cancers
Transgenic Plant Production - ProdiGene announces a research agreement to produce gelatin in maize
Whole Genome Amplification - Rubicon announces breakthrough in drug development
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.